No difference between direct-acting antivirals for hepatitis C in hepatocellular carcinoma risk.

od Mun, Elijah J., Green, Pamela, Berry, Kristin, Ioannou, George N.
Wydane w Eur J Gastroenterol Hepatol (2019)

Differences in hepatocellular carcinoma risk, predictors and trends over time according to etiology of cirrhosis

od Ioannou, George N., Green, Pamela, Lowy, Elliott, Mun, Elijah J., Berry, Kristin
Wydane w PLoS One (2018)

Development of Models Estimating the Risk of Hepatocellular Carcinoma After Antiviral Treatment for Hepatitis C

od Ioannou, George N., Green, Pamela K., Beste, Lauren A., Mun, Elijah J., Kerr, Kathleen F., Berry, Kristin
Wydane w J Hepatol (2018)